UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
336.40
+6.29 (1.91%)
At close: Jan 2, 2026, 4:00 PM EST
336.62
+0.22 (0.07%)
After-hours: Jan 2, 2026, 7:59 PM EST
UnitedHealth Group Market Cap
UnitedHealth Group has a market cap or net worth of $304.72 billion as of January 2, 2026. Its market cap has decreased by -33.58% in one year.
Market Cap
304.72B
Enterprise Value
357.65B
1-Year Change
-33.58%
Ranking
Category
Stock Price
$336.40
Market Cap Chart
Since December 1, 1998, UnitedHealth Group's market cap has increased from $8.37B to $304.72B, an increase of 3,541.28%. That is a compound annual growth rate of 14.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 304.72B | 1.91% |
| Dec 31, 2025 | 299.03B | -35.77% |
| Dec 31, 2024 | 465.54B | -4.40% |
| Dec 29, 2023 | 486.95B | -1.70% |
| Dec 30, 2022 | 495.37B | 4.74% |
| Dec 31, 2021 | 472.94B | 42.14% |
| Dec 31, 2020 | 332.73B | 19.46% |
| Dec 31, 2019 | 278.52B | 16.21% |
| Dec 31, 2018 | 239.66B | 12.18% |
| Dec 29, 2017 | 213.64B | 40.25% |
| Dec 30, 2016 | 152.33B | 35.86% |
| Dec 31, 2015 | 112.12B | 15.56% |
| Dec 31, 2014 | 97.03B | 27.99% |
| Dec 31, 2013 | 75.81B | 35.34% |
| Dec 31, 2012 | 56.01B | 3.68% |
| Dec 30, 2011 | 54.03B | 36.02% |
| Dec 31, 2010 | 39.72B | 12.14% |
| Dec 31, 2009 | 35.42B | 10.24% |
| Dec 31, 2008 | 32.13B | -57.28% |
| Dec 31, 2007 | 75.20B | 3.91% |
| Dec 29, 2006 | 72.37B | -8.08% |
| Dec 30, 2005 | 78.74B | 36.85% |
| Dec 31, 2004 | 57.54B | 68.58% |
| Dec 31, 2003 | 34.13B | 34.26% |
| Dec 31, 2002 | 25.42B | 15.22% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |
| Thermo Fisher Scientific | 222.61B |